@FierceMedDev: ICYMI: DOJ slaps Olympus with a subpoena over dirty duodenoscopes. Article | Follow @FierceMedDev
@VarunSaxena2: FMD exclusive (got insider tip): Zimmer to cut some staff as it barrels toward merger with Biomet. Story | Follow @VarunSaxena2
@EmilyWFierce: ICYMI from FiercePharma: Otsuka faces the music for generic Abilify, loses battle with FDA. Article | Follow @EmilyWFierce
> Illuminated surgical device company Invuity set its IPO terms to raise 4 million shares at a range of $14 to $16 each, raising $60 million at a mid-point and giving the company a $207 million valuation. Better-view-endoscopy player EndoChoice is expected to have its $100 million IPO around Thursday, June 4. More
> The FDA has cleared epidural placement guide Accuro from Rivana Medical. More
> Siemens has a new MRI system that's intended specifically for research and clinical use. It intends to go after CE mark and FDA authorization for select neurological and musculoskeletal applications. More
> Hologic ($HOLX) has raised $1.5 billion in a term loan and a $1 billion revolving credit facility. Most of this will go to repay its outstanding debt of $1.69 billion. More
Biotech News
@FierceBiotech: ASCO 15: The top 10 setbacks, advances and head scratchers. Editor's corner | Follow @FierceBiotech
@JohnCFierce: $IMGN shares up 14% on positive early data for ovarian cancer ADC. Release | Follow @JohnCFierce
> Bristol-Myers barrels toward approval with a blockbuster cancer combo. More
> Juno amps up its CAR-T tech in drive toward a pivotal test. Report
> Bristol-Myers fires off a lawsuit to sideline R&D defector headed to rival AstraZeneca. Story
> Alzheimer's biotech eyes $300M in a scaled-up IPO. Article
Pharma News
@FiercePharma: ICYMI: Adding Opdivo to Yervoy ups melanoma treatment efficacy--but it ups rate of serious side effects, too. Report | Follow @FiercePharma
@CarlyHFierce: UPDATED w/Genentech comment: Roche's Gazyva doubles remission time for non-Hodgkin lymphoma patients. Story | Follow @CarlyHFierce
> Top oncologist joins chorus of pricing critics in high-profile ASCO speech. More
> UCB reportedly gets bids for Kremers Urban unit from Cipla and Lupin. Article
Animal Health News
> Tech makers market health wearables to dog owners. Item
> Groundbreaking held for the new $1.2B NABF animal health facility in Kansas. More
> Bayer CEO Dekkers looking 'with interest' at animal-health additions. Report
> K-State researchers build avian-flu protection into existing poultry vaccine. Article
> Novozymes enters booming market for poultry probiotics. Story
Biotech IT News
> CRISPR Therapeutics starts search for a bioinformatics chief. More
> Bioinformatics leads UCSD team to ovarian cancer biomarkers. Story
> AstraZeneca's Definiens rolls out biomarker data service. Item
> Artificial intelligence tops Google VC's list of high-potential life sci techs. Article
> UT Southwestern snags $5.6M grant to boost bioinformatics operation. Report
Pharma Marketing News
> Stars of cancer meeting set to crack top 10 cancer sales by 2020. Article
> Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA. Report
> Novartis rolls out 'life hacks' for MS patients with new Live Like You campaign. Article
> ASCO must-reads: Pfizer's Ibrance; BMS, Novartis melanoma meds; J&J's Imbruvica and more. More
> Abbott takes Pedialyte on the festival circuit as grown-up hangover remedy. Story